Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1275, 2001-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Olanzapine - clinical benefit accounts for cost savings
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 300, 2001-01 ,pp. :
Access to resources
Recommend
Olanzapine: small benefit, greater cost vs haloperidol
Inpharma, Vol. 1, Iss. 1416, 2003-01 ,pp. :
By Yu Wei Ren Xinhua S. Lee Austin F. Herz Lawrence Huang Yu-Hui Kazis Lewis E.
PharmacoEconomics, Vol. 24, Iss. 12, 2006-01 ,pp. :
Sertraline: an assessment of clinical benefit and cost in the UK
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
Basiliximab confers significant clinical benefit for marginal cost
Inpharma, Vol. 1, Iss. 1374, 2003-01 ,pp. :